POstoperative bleeding and other outcomes in children with von Willebrand disease or low von Willebrand factor undergoing adenotonsillectomy

被引：0
|
作者：
Diaz, R. [1 ]
Mahoney, D. H., Jr. [1 ]
Musso, M. [2 ]
Yee, D. L. [1 ]
机构：
[1] Texas Childrens Hosp, Pediat, Houston, TX 77030 USA
[2] Baylor Coll Med, Otolaryngol, Houston, TX 77030 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO644-TUE
引用
收藏
页码：740 / 741
页数：2
相关论文
共 50 条
  • [41] Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels
    Lehmann, M.
    Ashworth, K.
    Manco-Johnson, M.
    Di Paola, J.
    Neeves, K. B.
    Ng, C. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (01) : 104 - 115
  • [42] Low von Willebrand Factor in Children and Adolescents A Review
    Srivaths, Lakshmi
    Kouides, Peter A.
    JAMA PEDIATRICS, 2021, 175 (10) : 1060 - 1067
  • [43] Bleeding in valvular heart disease: is von Willebrand factor the culprit?
    Bakhtari, Shirin
    Vincent, Flavien
    Susen, Sophie
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (05)
  • [44] Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome
    Stufano, Francesca
    Boscarino, Marco
    Bucciarelli, Paolo
    Baronciani, Luciano
    Maino, Alberto
    Cozzi, Giovanna
    Peyvandi, Flora
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (01): : 36 - 42
  • [45] Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    HAEMOPHILIA, 1998, 4 : 53 - 62
  • [46] In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease
    Turecek, PL
    Gritsch, H
    Pichler, L
    Auer, W
    Fischer, B
    Mitterer, A
    Mundt, W
    Schlokat, U
    Dorner, F
    Erinkman, HJM
    vanMourik, JA
    Schwarz, HP
    BLOOD, 1997, 90 (09) : 3555 - 3567
  • [47] Von Willebrand factor inhibitors developed in type 3 von Willebrand disease
    Megdiche, F.
    Kassar, O.
    Hdiji, S.
    Mbarek, L.
    Charfi, M.
    Elloumi, M.
    Kallel, C.
    HAEMOPHILIA, 2019, 25 : 87 - 87
  • [48] Reduced von Willebrand factor survival in type Vicenza von Willebrand disease
    Casonato, A
    Pontara, E
    Sartorello, F
    Cattini, MG
    Sartori, MT
    Padrini, R
    Girolami, A
    BLOOD, 2002, 99 (01) : 180 - 184
  • [49] Hypersensitivity to von Willebrand factor and von Willebrand disease: A case-report
    Carneiro-Leao, D.
    Queiros, R.
    Mota, T.
    Fernandes, S.
    Lopes, M.
    Koch, M. D. C.
    HAEMOPHILIA, 2024, 30 : 131 - 132
  • [50] Four novel von Willebrand factor mutations in mild von Willebrand disease
    Castaman, G.
    Giacomelli, S.
    Coppola, A.
    Rodeghiero, F.
    Tosetto, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 943 - 943
12345